ABCG2 and acute myeloid leukemia: Furthermore, relapsed patients with acute myeloid leukemia (AML) had a more substantial proportion of LSCs along with enhanced breast cancer resistant protein (BCRP) and P-glycoprotein (P-gp) as compared with untreated patients26.